References
- FruehFWAmurSMummaneniPPharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: prevalence of related drug usePharmacotherapy200828899299818657016
- US Food and Drug AdministrationTable of Pharmacogenomic Biomarkers in Drug Labels Available from: http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htmAccessed May 13, 2014
- CharlandSLAgatepBCHerreraVProviding patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trialPharmacogenomics J201414327228023979174
- US Food and Drug AdministrationRequirements on content and format of labeling for human prescription drug and biological products. January 24, 71 FR 39222006Code of Federal Regulations §§ 201.56 and 201.57 Available from: http://www.fda.gov/ohrms/dockets/98fr/06-545.pdfAccessed July 22, 2014
- US Food and Drug AdministrationLabeling for human prescription drug and biological products – implementing the PLR content and format requirements22013 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075082.pdfAccessed May 13, 2014
- US Food and Drug AdministrationGuidance for industry: patient counseling information section of labeling for human prescription drug and biological products – content and format92013 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368602.pdfAccessed May 13, 2014
- US Food and Drug AdministrationPatient package inserts for oral contraceptives Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=310.50121CFR310.501Accessed July 22, 2014
- US Food and Drug AdministrationPatient package inserts for estrogens. 21CFR310.515 Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=310.515Accessed July 22, 2014
- US Food and Drug AdministrationMedication guides for prescription drug products. 21CFR208 Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=208.20Accessed July 22, 2014
- StewartMBrownJBDonnerAThe impact of patient-centered care on outcomesJ Fam Pract200049979680411032203
- WeinerSJSchwartzASharmaGPatient-centered decision making and health care outcomes: an observational studyAnn Intern Med2013158857357923588745
- McMillanSSKendallESavAPatient-centered approaches to health care: a systematic review of randomized controlled trialsMed Care Res Rev201370656759623894060
- ConradoDJRogersHLZinehIPacanowskiMAConsistency of drug-drug and gene-drug interaction information in US FDA-approved drug labelsPharmacogenomics201314221522323327581
- SeminerioMJRatainMJAre drug labels static or dynamic?Clin Pharmacol Ther201394330230423963217
- DrozdaKMullerDJBishopJRPharmacogenomic testing for neuropsy-chiatric drugs: current status of drug labeling, guidelines for using genetic information, and test optionsPharmacotherapy201434216618424523097
- OtsuboYAsahinaYNoguchiASatoYAndoYUyamaYSimilarities and differences between US and Japan as to pharmacogenomic biomarker information in drug labelsDrug Metab Pharmacokinet201227114214922201121
- ShimazawaRIkedaMDifferences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and JapanJ Clin Pharm Ther201338646847523895776
- Depakene (valproic acid): prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018081s056lbl.pdfAccessed July 22, 2014
- Ziagen (abacavir sulfate) medication guide2012 Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm224556.pdfAccessed July 22, 2014
- Revlimid (lenalidomide) medication guide2013 Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm111335.pdfAccessed July 22, 2014
- Gilotrif (afatinib) prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201292s002lbl.pdfAccessed July 22, 2014
- Xeloda (capecitabine) prescribing information2010 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020896s026lbl.pdfAccessed July 22, 2014
- Carac (fluorouracil) prescription information2003 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20985slr004_carac_lbl.pdfAccessed July 22, 2014
- Aczone (dapsone) prescribing information2009 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021794s006lbl.pdfAccessed July 22, 2014
- Codeine sulfate prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022402s006lbl.pdfAccessed July 22, 2014
- Krystexxa (pegloticase) medication guide2012 Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM227568.pdfAccessed July 22, 2014
- Zelboraf (vemurafenib) prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202429s002s003lbl.pdfAccessed July 22, 2014
- Allen LaPointeNMPappasPDeverkaPAnstromKJPatient receipt and understanding of written information provided with isotretinoin and estrogen prescriptionsJ Gen Intern Med20072219810117351847
- WolfMSDavisTCShrankWHNeubergerMParkerRMA critical review of FDA-approved medication guidesPatient Educ Counsel2006623316322
- WolfMSKingJWilsonEAUsability of FDA-approved medication guidesJ Gen Intern Med201227121714172022566170
- ShiffmanSGerlachKKSembowerMARohayJMConsumer understanding of prescription drug information: an illustration using an antidepressant medicationAnn Pharmacother201145445245821427296
- RoseDRussoJWykesTTaking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent processBMC Med Ethics2013143424025622
- StormABenfeldtEAndersenSEAndersenJBasic drug information given by physicians is deficient, and patients’ knowledge lowJ Dermatolog Treat200920419019319040185
- NairKDolovichLCasselsAWhat patients want to know about their medicationsCan Fam Physician20024810411011852597
- DickinsonDRaynorDKWhat information do patients need about medicines? Ask the patients – they may want to know more than you thinkBMJ2003327741986114551106
- McCormackJPDolovichLLevineMProviding evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?Health Expect20036428128915040790
- NathanJPZerilliTCiceroLARosenbergJMPatients’ use and perception of medication information leafletsAnn Pharmacother200741577778217405820
- SchmittMRMillerMJHarrisonDLCommunicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients’ risk awarenessPatient Educ Counsel2011833391397
- RaynorDKSavageIKnappPHenleyJWe are the experts: people with asthma talk about their medicine information needsPatient Educ Counsel2004532167174
- US Food and Drug AdministrationInformation for Consumers (drugs)2014 Available from: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/default.htmAccessed May 13, 2014
- US Food and Drug AdministrationDevelopment and distribution of patient medication information for prescription drugs; public hearingUS Department of Health and Human Services Federal Register2010751665276552768 Available from: http://www.fda.gov/drugs/newsevents/ucm219716.htmAccessed July 22, 2014
- BerryDCRaynorDKKnappPBerselliniEPatients’ understanding of risk associated with medication use – impact of European Commission guidelines and other risk scalesDrug Saf200326111112495359